Although no market response, imo it still remains very re-assuring to know that everything this collaborating new board has touched turned to gold.
Bring on June now, unless of course bod decides to release some much anticipated (overdue) news in the interim?
Bloody biotechs, I love them, but they demand so much patience from investors.
On a positive note, should the Australian market continue it's downward spiral excellent buying opportunities always present themselves...
I'm expecting the US markets to continue rallying through to mid June but Australian investors as it would appear are running a completely different course atm...?
BOD Price at posting:
4.8¢ Sentiment: LT Buy Disclosure: Held